Concepedia

Frank Boess

FB

Statistics

Publications

39

Citations

3.9K

H-Index

28

Active since

1990

Affiliations

Roche (Switzerland)(Current)

Eli Lilly (Germany)

Bayer (Germany)

Prothena (United States)

University of California San Diego

Frank Boess is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1990–2022

39

Publications

39

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

Viktor Lakics, Eric Karran, Frank Boess · Neuropharmacology · 2010 · 456 citations

, , +8

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

Gennaro Pagano, Kirsten I. Taylor, Judith Anzures‐Cabrera et al. · New England Journal of Medicine · 2022 · 363 citations · Full text

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

Frank Boess, Martin Hendrix, F. Josef van der Staay et al. · Neuropharmacology · 2004 · 324 citations · Full text

, , +11

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease

Joseph Jankovic, Ira Goodman, Beth Safirstein et al. · JAMA Neurology · 2018 · 283 citations · Full text

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Florian Lipsmeier, Kirsten I. Taylor, Timothy Kilchenmann et al. · Movement Disorders · 2018 · 259 citations · Full text

1–5 of 39